Veterinary Medicines

IZOVAC ILT liofilizzato e solvente per sospensione oculo-nasale per polli

Authorised
  • Avian infectious laryngotracheitis virus, strain PV/64, Live
Download as PDF

Product identification

Medicine name:
IZOVAC ILT liofilizzato e solvente per sospensione oculo-nasale per polli
Active substance:
  • Avian infectious laryngotracheitis virus, strain PV/64, Live
Target species:
  • Chicken
  • Chicken (pullet)
Route of administration:
  • Oculonasal use

Product details

Active substance and strength:
  • Avian infectious laryngotracheitis virus, strain PV/64, Live
    2.50
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken
      • Meat and offal
        0
        day
    • Chicken (pullet)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD08
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Izo S.r.l.
Marketing authorisation date:
This information is not available for this product.
Manufacturing sites for batch release:
  • Izo S.r.l.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104890
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 23/11/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."